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During neurogenesis, multiple regu-latory networks integrate extracel-
lular and intracellular signals to ensure 
proper final numbers for each neuronal 
subtype at the end of the developmen-
tal process. The Activin/TGF-β signal-
ing cascade is one of the main players 
of neurogenesis in vertebrates, balanc-
ing proliferation and differentiation 
of neural stem cells by regulating gene 
expression via the R-Smads transcrip-
tion factors. Despite their equivalent 
upstream activation mechanism, Smad2 
and Smad3 functions can be redundant 
or opposite depending on the particu-
lar context of the cell. We demonstrate 
that R-Smad simultaneously cooperate 
and antagonize in the regulation of gene 
expression in the context of vertebrate 
neurogenesis. We propose a model where 
synergism and antagonism appear as a 
consequence of the competition between 
Smad2 and Smad3 to form the differ-
ent transcriptionally active heterotri-
mers with Smad4. This dual interplay 
of R-Smads significantly modulates the 
role of TGF-β pathway in the balance 
between proliferation and differentiation 
in the developing vertebrate spinal cord.
Transforming growth factor β (TGF-
β) superfamily is one of the main classes 
of multi-tasking secreted proteins that 
drives animal development.1 There are 2 
branches in this family: bone morpho-
genic proteins (BMP) and Nodal/Activin/
TGF-β, which orchestrate several key 
processes during embryogenesis.2 Act-
ing through Smad transcription factors, 
they regulate a variety of cellular func-
tions including cell proliferation, growth 
arrest, differentiation and migration. The 
canonical TGF-β pathway begins with 
the binding of TGF-β ligands to different 
isoforms of type II and I Ser/Thr kinase 
receptors at the cell membrane.3 The 
ligand promotes receptor dimerization, 
enabling the phosphorylation and acti-
vation of the receptor type I by the type 
II. Specifically, activated Nodal/Activin/
TGF-β receptor complexes recruit and 
phosphorylate Smad2 and Smad3 pro-
teins, which oligomerize with Smad4 to 
form transcriptionally active heterotri-
mers. These active complexes translocate 
into the nucleus where they regulate gene 
expression (Fig. 1A).4-6
Despite this apparently simple mecha-
nism of activation, the Nodal/Activin/
TGF-β pathway plays major and diverse 
roles during embryo development. The 
concentration gradient of Nodal is essen-
tial for the establishment of the anterior–
posterior (A/P) axis and the induction of 
the mesendoderm layer. Subsequently, 
together with BMPs, they organize the 
left–right (L/R) asymmetry, finishing the 
specification of the body plan.1,7 Coun-
teracting BMP and Shh gradients regu-
late closure and dorsal–ventral (D/V) 
polarization of the neural tube.8-10 BMP/
Activin ligands are expressed dorsally 
in the newly originated neural tube,11 
whereas TGF-β 2, 3 isoforms are prefer-
entially expressed in the notochord and 
the floor plate,12,13 concomitant with 
Shh expression. The opposing gradi-
ents of these ligands are involved in the 
specification pattern for each neuronal 
subtype in the neural tube. Nonetheless, 
the particular functions of each mem-
ber of the Activin/TGF-β subfamily 
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during neurogenesis are beginning to be 
understood.
In the dorsal pole of the neural tube, 
Activin signaling promotes the formation 
of the dorsal interneuron 3 (dI3) precursor 
cells.14 Besides, TGF-β factors contribute 
to regulate the balance between prolif-
eration and differentiation of neural stem 
cells in conjunction with other pathways. 
TGF-β counterbalances the proliferative 
signals of IGF1/AKT in the forebrain 
and Wnt/FGF8 in the midbrain.15,16 In 
addition, TGF-β1 signaling participates 
in neuronal differentiation by modulat-
ing the expression of regulators of the cell 
cycle,17,18 whereas the isoforms TGF-β2,3 
are essential for the specification of dopa-
minergic neurons induced by Shh.19
The role of Activin/TGF-β signal-
ing in the regulation of neurogenesis is 
ultimately mediated by the downstream 
transcription factors Smad2 and Smad3. 
Particularly, Smad3 triggers the differ-
entiation program of ventral interneu-
ron progenitors through transcription 
of bHLH proteins such as NeuroM and 
Mash1, inhibition of Id1,2,20,21 and pro-
moting cell-cycle exit by transcribing 
cell-cycle inhibitors p15, p21, or p27.17,20,21 
In contrast, Smad2 activity is correlated 
with Nodal signaling throughout embryo-
genesis, including A/P patterning and 
endoderm formation, although its spe-
cific function in vertebrate neurogenesis 
remains unclear.7 However, recent studies 
suggest a role of Smad2 in the regulation 
of axonal morphogenesis in telencephalon 
and metencephalon,22,23 which correlates 
with the pro-survival effects that TGF-β 
has in neurons in other contexts.24,25 The 
role of Smad2 in neurogenesis appears to 
be related to SnoN, a modulator of axo-
nal development and growth.26 The SnoN 
pathway is receiving increased importance 
during embryogenesis, since recent find-
ings suggest a high convergence with other 
important pathways, including Nodal/
TGF-β27 and cell cycle regulators such as 
p53 and APC/Cdh1.28 Furthermore, in 
some cell lines, SnoN expression seems to 
be positively and negatively regulated by 
both R-Smads, revealing a potential impli-
cation of both R-Smads in this pathway.29
Related to the expression profile, Smad2 
is widely distributed in the neuroepithe-
lium, and latterly in the telencephalon 
and metencephalon.30 Nonetheless, in 
the context of the developing neural tube, 
Smad2 was not detected in previous stud-
ies.20 We showed that Smad2 is expressed 
in the ventricular zone of the developing 
spinal cord in the chick neural tube, and 
that its expression partially overlaps with 
the expression pattern of Smad3, which 
is a requirement for a potential interplay 
between both R-Smads at the cellular 
level.31
As reviewed above, Smad2 and Smad3 
are functionally nonequivalent,5,32 despite 
their common upstream activation mech-
anism and their 92% identity in their 
amino acid sequences.32-34 Knockout (KO) 
studies in mice, show early embryonic 
lethality in Smad2 KO. This was attrib-
uted to disruption of the A/P axis within 
the epiblast and failure in the formation 
of the ectoderm, mesoderm, and endo-
derm.34 In contrast, the KO of Smad3 is 
not embryonic lethal, although mice pres-
ent deficiencies in the immune response 
and high predisposition to tumorgenesis.35 
In addition, Smad2 and Smad3 have been 
shown to recruit different co-factors and 
target different regulatory sequences.36 
In particular, Smad3 binds directly to a 
CAGA-box in the promoter of PAI-1 or 
c-Jun, whereas Smad2 binds indirectly 
through Smad4 and co-factors, such 
as FoxH1 and Mix families, to Activin 
response elements (ARE) or other regula-
tory sequences.33,37 Moreover, recent stud-
ies suggest that cell-type specific master 
transcription factors such as Oct4, Myod1, 
or PU.1 determine Smad2 and Smad3 tar-
gets, and hence direct TGF-β effects in a 
context-dependent manner.38
Despite the important and multiple 
functions of the TGF-β signaling in many 
cellular processes and diseases,39,40 there 
are still relevant open questions regard-
ing to the global mechanisms that govern 
TGF-β dynamics and function, with the 
2 R-Smads playing redundant roles in 
some scenarios9,10 while antagonizing in 
others.41,42
To answer the question of how these 
2 highly similar molecules targeting dif-
ferent DNA regulatory sequences can 
synergize or antagonize depending on the 
cellular context, we compared the func-
tion of both R-Smads in the context of 
vertebrate neurogenesis.31 Our studies 
revealed a simultaneous cooperation and 
antagonism between Smad2 and Smad3 
occurring at the same cellular context. 
Experiments performed in the chick neu-
ral tube by in ovo electroporation showed 
an increase of Smad3-sepecific transcrip-
tion targets after Smad2-Smad3 gain of 
function (GOF) compared with wild-
type (WT) or Smad3 GOF alone. Sur-
prisingly, Smad2 loss of function (LOF) 
also induced a strong increase of Smad3 
activity (Fig. 1B). Additionally, Smad2-
Smad3 GOF resulted in an increase of 
the amount of neural progenitors under-
going differentiation, specifically of ven-
tral interneurons, compared with WT or 
GOF of Smad3.20 Correspondingly, LOF 
of Smad2 also induced a strong increase 
in differentiation, compared with the WT 
situation.
In order to address the potential under-
lying mechanisms that could induce this 
dual interplay between the R-Smads, we 
followed a computational approach. Pre-
vious models of the TGF-β signaling 
pathway focused on the dynamics of the 
nucleocytoplasmic shuttling of R-Smad 
complexes,43 the dynamics of signal 
processing, the generation of transient 
responses,44 and endocytosis.45 Most of 
these mathematical models assume that 
Smad2 and Smad3 are indistinguishable. 
These approaches take advantage of a 
detailed characterization of several poten-
tial interactions in the pathway to under-
stand the effect of different regulatory 
mechanisms and crosstalks.46
Contrary, our modeling approach 
focused on the R-Smads oligomerization 
after phosphorylation, in order to under-
stand the dual antagonism/cooperation 
observed experimentally. This minimal 
model successfully reproduced all experi-
mental results when we allowed the het-
erotrimer Smad2-Smad3-Smad4 to bind 
and regulate transcription in Smad3-spe-
cific regulatory sequences. We observed 
by co-inmunoprecipitation that Smad2 
and Smad3 physically interact in a com-
plex with Smad4, and that the amount of 
Smad3 bound to Smad4 depended on the 
amount of Smad2 available and vice versa. 
The affinity of phosphorylated Smad2 to 
form trimers with Smad2 vs. Smad3 is 
unknown. Nonetheless, the model pre-
dicted stronger affinity of the R-Smads 
www.landesbioscience.com neurogenesis e29529-3
Figure 1. Scheme of the tGF-β pathway. (A) (1) Dimers of soluble activin or tGF-β ligands bind their specific Ser/thr kinase receptor type II, presented 
by the co-receptor betaglycan. (2) the complex oligomerizes and phosphorylates receptor type I and finally forms the tetrameric active ligand-receptor 
complex. (3) this complex phosphorylates r-Smad transcription factors (Smad2 in green and Smad3 in blue), recruited to plasma membrane by the 
anchor protein Sara. (4) Heterodimers or homodimers of r-Smad bind the Co-Smad (Smad4) to form the transcriptionally active heterotrimers. (5) Smad 
oligomers are actively transported to the nucleus, where (6) they bind to specific promoter regions and regulate gene expression. Specifically, Smad2-
Smad2-Smad4 homotrimer is recruited to are while Smad3-Smad3-Smad4 homotrimer and Smad3-Smad2-Smad4 heterotrimer bind to CaGa box in 
the promoter regions of their target genes. (B) In the basal state Smad2 directed transcription (are) is accomplished only by Smad2-Smad2-Smad4 
homotrimer while Smad3 targets (CaGa box) are regulated by both Smad3-Smad2-Smad4 and Smad3-Smad3-Smad4 trimers. Increasing the levels of 
Smad2 (Smad2 GoF) shifts the balance to overexpress Smad2 targets (are). Similarly, Smad3 GoF leads to overexpression of Smad3 targets. Depletion 
of Smad2 protein (Smad2 LoF) contributes not only to downregulate Smad2 targets, but also to increase Smad3 driven transcription.
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to form the heterotrimer Smad2-Smad3-
Smad4, than Smad2-Smad2-Smad4 or 
Smad3-Smad3-Smad4.
Overall, our results evidence a scenario 
of competition between R-Smad to form 
the 3 potential heterotrimers that depends 
on the concentration and the binding 
affinities of the R-Smads. Thus, the selec-
tion between cooperation and antagonism 
of the R-Smads is not cell type-dependent, 
occurring in the same cellular context as 
a consequence of the interaction between 
Smad2, Smad3, and Smad4.
Many aspects of the TGF-β path-
way were not included in the analysis 
for the sake of simplicity. In our model, 
we assumed Michaelis–Menten kinet-
ics for the phosphorylation dynamics of 
the R-Smads, and therefore the amount 
of phosphorylated R-Smads depended 
directly on the amount of available 
R-Smads after receptor activation. More-
over, we considered that protein pro-
duction and degradation are balanced. 
Consequently, the concentration of each 
R-Smad was assumed constant. A more 
detailed analysis of our model, includ-
ing a full mathematical description of the 
known interactions of the TGF-β path-
way, remains to be studied. Potential can-
didates to include in the model are com-
partmentalization, nucleo-cytoplasmatic 
translocation of the R-Smads,47 and inhi-
bition by I-Smads (Smad6 and Smad7) 
and E3 ligases.48 The I-Smads induce a 
well-characterized negative feedback loop 
that can induce nonlinear effects, such as 
desensitization of the pathway and robust-
ness against perturbations.49 Interestingly, 
some E3 ligases such as Arkadia have been 
demonstrated to positively contribute to 
TGF-β signaling. Arkadia has an essential 
role during embryogenesis because, under 
TGF-β activation, it degrades negative 
feedback inhibitors of the pathway, such 
as Smad7 and SnoN, a negative co-factor 
for Smad3/4 directed transcription.44,50 
All these potential interactions will result 
in a more realistic mathematical approxi-
mation to the true dynamics of the path-
way, but the increasing complexity and 
the amount of unknown reaction param-
eters will complicate the analysis and the 
understanding of the consequences of the 
interplay between the R-Smads.
The arising characteristics of the 
TGF-β system constitute a paradigm of 
how the network of interactions can deter-
mine the strength, dynamics and even the 
function of proteins in a given pathway. 
These emerging characteristics induced 
by a complex network have been studied 
widely in biological systems.51 In the con-
text of neurogenesis, Shh graded responses 
have been proposed to be interpreted via 
a nonlinear network of interacting genes.8 
In addition, domain specification of the 
neural tube has been also shown to be reg-
ulated by a network of interacting genes 
with multiple interconnected positive and 
negative feedback loops.52 For instance, a 
feedback in Delta-Notch signaling that 
mediates lateral inhibition is key in the 
regulation of pro-neural genes and neural 
differentiation.53 In fact, the characteriza-
tion of the interactions within the network 
has been shown to be decisive for a full 
understanding of different developmental 
processes like somite formation,54 palate,55 
and digit formation in mice56 and pigmen-
tation pattern in animal skin57 and also 
in treatment and prognosis of patholo-
gies such as cancer.58-60 These studies evi-
dence that a complete understanding of 
the TGF-β and other signaling networks 
involved in neurogenesis should take into 
account not only the study of the bio-
chemical aspects of the proteins, but also 
the analysis of the interaction network.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were 
disclosed.
References
1. Wu MY, Hill CS. Tgf-β superfamily signaling in 
embryonic development and homeostasis. Dev Cell 
2009; 16:329-43; PMID:19289080; http://dx.doi.
org/10.1016/j.devcel.2009.02.012
2. Oshimori N, Fuchs E. The harmonies played 
by TGF-β in stem cell biology. Cell Stem Cell 
2012; 11:751-64; PMID:23217421; http://dx.doi.
org/10.1016/j.stem.2012.11.001
3. Feng XH, Derynck R. Specificity and versatility 
in tgf-β signaling through Smads. Annu Rev Cell 
Dev Biol 2005; 21:659-93; PMID:16212511; 
h t t p : / / d x . d o i . o r g / 1 0 . 1 1 4 6 / a n n u r e v .
cellbio.21.022404.142018
4. Heldin CHH, Miyazono K, ten Dijke P. TGF-β 
signalling from cell membrane to nucleus through 
SMAD proteins. Nature 1997; 390:465-71; 
PMID:9393997; http://dx.doi.org/10.1038/37284
5. Massagué J, Seoane J, Wotton D. Smad 
transcription factors. Genes Dev 2005; 19:2783-
810; PMID:16322555; http://dx.doi.org/10.1101/
gad.1350705
6. ten Dijke P, Hill CS. New insights into TGF-β-
Smad signalling. Trends Biochem Sci 2004; 29:265-
73; PMID:15130563; http://dx.doi.org/10.1016/j.
tibs.2004.03.008
7. Brennan J, Lu CC, Norris DP, Rodriguez TA, 
Beddington RS, Robertson EJ. Nodal signalling in 
the epiblast patterns the early mouse embryo. Nature 
2001; 411:965-9; PMID:11418863; http://dx.doi.
org/10.1038/35082103
8. Dessaud E, McMahon AP, Briscoe J. Pattern 
formation in the vertebrate neural tube: a sonic 
hedgehog morphogen-regulated transcriptional 
network. Development 2008; 135:2489-503; 
PMID:18621990; http://dx.doi.org/10.1242/
dev.009324
9. Jia S, Wu D, Xing C, Meng A. Smad2/3 activities 
are required for induction and patterning of the 
neuroectoderm in zebrafish. Dev Biol 2009; 333:273-
84; PMID:19580801; http://dx.doi.org/10.1016/j.
ydbio.2009.06.037
10. Jia S, Ren Z, Li X, Zheng Y, Meng A. smad2 and 
smad3 are required for mesendoderm induction 
by transforming growth factor-beta/nodal signals 
in zebrafish. J Biol Chem 2008; 283:2418-26; 
PMID:18025082; http://dx.doi.org/10.1074/jbc.
M707578200
11. Liu A, Niswander LA. Bone morphogenetic protein 
signalling and vertebrate nervous system development. 
Nat Rev Neurosci 2005; 6:945-54; PMID:16340955; 
http://dx.doi.org/10.1038/nrn1805
12. Liem KFJ Jr., Tremml G, Jessell TM. A role for the 
roof plate and its resident TGFbeta-related proteins 
in neuronal patterning in the dorsal spinal cord. Cell 
1997; 91:127-38; PMID:9335341; http://dx.doi.
org/10.1016/S0092-8674(01)80015-5
13. Cooley JR, Yatskievych TA, Antin PB. Embryonic 
expression of the transforming growth factor β 
ligand and receptor genes in chicken. Dev Dyn 
2014; 243:497-508; PMID:24166734; http://dx.doi.
org/10.1002/dvdy.24085
14. Timmer J, Chesnutt C, Niswander L. The activin 
signaling pathway promotes differentiation of dI3 
interneurons in the spinal neural tube. Dev Biol 
2005; 285:1-10; PMID:16039645; http://dx.doi.
org/10.1016/j.ydbio.2005.05.039
15. Seoane J, Le HV, Shen L, Anderson SA, Massagué 
J. Integration of Smad and forkhead pathways in 
the control of neuroepithelial and glioblastoma 
cell proliferation. Cell 2004; 117:211-23; 
PMID:15084259; http://dx.doi.org/10.1016/
S0092-8674(04)00298-3
16. Falk S, Wurdak H, Ittner LM, Ille F, Sumara G, 
Schmid MT, Draganova K, Lang KS, Paratore 
C, Leveen P, et al. Brain area-specific effect of 
TGF-β signaling on Wnt-dependent neural stem 
cell expansion. Cell Stem Cell 2008; 2:472-83; 
PMID:18462697; http://dx.doi.org/10.1016/j.
stem.2008.03.006
17. Misumi S, Kim TSS, Jung CG, Masuda T, Urakawa 
S, Isobe Y, Furuyama F, Nishino H, Hida H. 
Enhanced neurogenesis from neural progenitor 
cells with G1/S-phase cell cycle arrest is mediated 
by transforming growth factor β1. Eur J Neurosci 
2008; 28:1049-59; PMID:18783370; http://dx.doi.
org/10.1111/j.1460-9568.2008.06420.x
18. Gomes FC, Sousa VdeO, Romão L. Emerging roles 
for TGF-β1 in nervous system development. Int J 
Dev Neurosci 2005; 23:413-24; PMID:15936920; 
http://dx.doi.org/10.1016/j.ijdevneu.2005.04.001
19. Farkas LM, Dünker N, Roussa E, Unsicker K, 
Krieglstein K. Transforming growth factor-β(s) 
are essential for the development of midbrain 
dopaminergic neurons in vitro and in vivo. J Neurosci 
2003; 23:5178-86; PMID:12832542
www.landesbioscience.com neurogenesis e29529-5
20. García-Campmany L, Martí E. The TGFbeta 
intracellular effector Smad3 regulates neuronal 
differentiation and cell fate specification in the 
developing spinal cord. Development 2007; 134:65-
75; PMID:17138664; http://dx.doi.org/10.1242/
dev.02702
21. Estarás C, Akizu N, García A, Beltrán S, de la Cruz 
X, Martínez-Balbás MA. Genome-wide analysis 
reveals that Smad3 and JMJD3 HDM co-activate 
the neural developmental program. Development 
2012; 139:2681-91; PMID:22782721; http://dx.doi.
org/10.1242/dev.078345
22. Ueberham U, Lange P, Ueberham E, Brückner MK, 
Hartlage-Rübsamen M, Pannicke T, Rohn S, Cross M, 
Arendt T. Smad2 isoforms are differentially expressed 
during mouse brain development and aging. Int J Dev 
Neurosci 2009; 27:501-10; PMID:19375497; http://
dx.doi.org/10.1016/j.ijdevneu.2009.04.001
23. Wang L, Nomura M, Goto Y, Tanaka K, Sakamoto R, 
Abe I, Sakamoto S, Shibata A, Enciso PL, Adachi M, 
et al. Smad2 protein disruption in the central nervous 
system leads to aberrant cerebellar development and 
early postnatal ataxia in mice. J Biol Chem 2011; 
286:18766-74; PMID:21464123; http://dx.doi.
org/10.1074/jbc.M111.223271
24. Pineda JR, Daynac M, Chicheportiche A, Cebrian-
Silla A, Sii Felice K, Garcia-Verdugo JM, Boussin FD, 
Mouthon MA. Vascular-derived TGF-β increases 
in the stem cell niche and perturbs neurogenesis 
during aging and following irradiation in the adult 
mouse brain. EMBO Mol Med 2013; 5:548-62; 
PMID:23526803; http://dx.doi.org/10.1002/
emmm.201202197
25. Brionne TC, Tesseur I, Masliah E, Wyss-Coray T. 
Loss of TGF-β 1 leads to increased neuronal cell 
death and microgliosis in mouse brain. Neuron 
2003; 40:1133-45; PMID:14687548; http://dx.doi.
org/10.1016/S0896-6273(03)00766-9
26. Stegmüller J, Huynh MA, Yuan Z, Konishi Y, Bonni 
A. TGFbeta-Smad2 signaling regulates the Cdh1-
APC/SnoN pathway of axonal morphogenesis. J 
Neurosci 2008; 28:1961-9; PMID:18287512; http://
dx.doi.org/10.1523/JNEUROSCI.3061-07.2008
27. Zhu Q, Kim YH, Wang D, Oh SP, Luo K. SnoN 
facilitates ALK1-Smad1/5 signaling during 
embryonic angiogenesis. J Cell Biol 2013; 202:937-
50; PMID:24019535; http://dx.doi.org/10.1083/
jcb.201208113
28. Zhu Q, Luo K. SnoN in regulation of embryonic 
development and tissue morphogenesis. FEBS Lett 
2012; 586:1971-6; PMID:22710172; http://dx.doi.
org/10.1016/j.febslet.2012.03.005
29. Zhu Q, Pearson-White S, Luo K. Requirement 
for the SnoN oncoprotein in transforming growth 
factor beta-induced oncogenic transformation of 
fibroblast cells. Mol Cell Biol 2005; 25:10731-
44; PMID:16314499; http://dx.doi.org/10.1128/
MCB.25.24.10731-10744.2005
30. de Sousa Lopes SM, Carvalho RL, van den 
Driesche S, Goumans MJ, ten Dijke P, Mummery 
CL. Distribution of phosphorylated Smad2 
identifies target tissues of TGF β ligands in mouse 
development. Gene Expr Patterns 2003; 3:355-
60; PMID:12799085; http://dx.doi.org/10.1016/
S1567-133X(03)00029-2
31. Míguez DG, Gil-Guiñón E, Pons S, Martí E. Smad2 
and Smad3 cooperate and antagonize simultaneously 
in vertebrate neurogenesis. J Cell Sci 2013; 126:5335-
43; PMID:24105267; http://dx.doi.org/10.1242/
jcs.130435
32. Brown KA, Pietenpol JA, Moses HL. A tale of two 
proteins: differential roles and regulation of Smad2 
and Smad3 in TGF-beta signaling. J Cell Biochem 
2007; 101:9-33; PMID:17340614; http://dx.doi.
org/10.1002/jcb.21255
33. Dennler S, Huet S, Gauthier JM. A short amino-acid 
sequence in MH1 domain is responsible for functional 
differences between Smad2 and Smad3. Oncogene 
1999; 18:1643-8; PMID:10102636; http://dx.doi.
org/10.1038/sj.onc.1202729
34. Dunn NR, Koonce CH, Anderson DC, Islam A, 
Bikoff EK, Robertson EJ. Mice exclusively expressing 
the short isoform of Smad2 develop normally and 
are viable and fertile. Genes Dev 2005; 19:152-
63; PMID:15630024; http://dx.doi.org/10.1101/
gad.1243205
35. Ashcroft GS, Yang X, Glick AB, Weinstein M, 
Letterio JL, Mizel DE, Anzano M, Greenwell-Wild 
T, Wahl SM, Deng C, et al. Mice lacking Smad3 show 
accelerated wound healing and an impaired local 
inflammatory response. Nat Cell Biol 1999; 1:260-6; 
PMID:10559937; http://dx.doi.org/10.1038/12971
36. Morikawa M, Koinuma D, Miyazono K, Heldin 
CH. Genome-wide mechanisms of Smad binding. 
Oncogene 2013; 32:1609-15; PMID:22614010; 
http://dx.doi.org/10.1038/onc.2012.191
37. Derynck R, Zhang Y, Feng XH. Smads: 
transcriptional activators of TGF-β responses. Cell 
1998; 95:737-40; PMID:9865691; http://dx.doi.
org/10.1016/S0092-8674(00)81696-7
38. Mullen AC, Orlando DA, Newman JJ, Lovén J, 
Kumar RM, Bilodeau S, Reddy J, Guenther MG, 
DeKoter RP, Young RA. Master transcription factors 
determine cell-type-specific responses to TGF-β 
signaling. Cell 2011; 147:565-76; PMID:22036565; 
http://dx.doi.org/10.1016/j.cell.2011.08.050
39. Akhurst RJ, Hata A. Targeting the TGFβ signalling 
pathway in disease. Nat Rev Drug Discov 2012; 
11:790-811; PMID:23000686; http://dx.doi.
org/10.1038/nrd3810
40. Massagué J. TGFbeta in Cancer. Cell 2008; 134:215-
30; PMID:18662538; http://dx.doi.org/10.1016/j.
cell.2008.07.001
41. Labbé E, Silvestri C, Hoodless PA, Wrana JL, 
Attisano L. Smad2 and Smad3 positively and 
negatively regulate TGF β-dependent transcription 
through the forkhead DNA-binding protein FAST2. 
Mol Cell 1998; 2:109-20; PMID:9702197; http://
dx.doi.org/10.1016/S1097-2765(00)80119-7
42. Yang YCC, Piek E, Zavadil J, Liang D, Xie D, Heyer 
J, Pavlidis P, Kucherlapati R, Roberts AB, Böttinger 
EP. Hierarchical model of gene regulation by 
transforming growth factor β. Proc Natl Acad Sci U 
S A 2003; 100:10269-74; PMID:12930890; http://
dx.doi.org/10.1073/pnas.1834070100
43. Schmierer B, Tournier AL, Bates PA, Hill 
CS. Mathematical modeling identifies Smad 
nucleocytoplasmic shuttling as a dynamic signal-
interpreting system. Proc Natl Acad Sci U S A 2008; 
105:6608-13; PMID:18443295; http://dx.doi.
org/10.1073/pnas.0710134105
44. Nicklas D, Saiz L. Characterization of negative 
feedback network motifs in the TGF-β 
signaling pathway. PLoS One 2013; 8:e83531; 
PMID:24386222; http://dx.doi.org/10.1371/
journal.pone.0083531
45. Cellière G, Fengos G, Hervé M, Iber D. 
Plasticity of TGF-β signaling. BMC Syst Biol 
2011; 5:184; PMID:22051045; http://dx.doi.
org/10.1186/1752-0509-5-184
46. Zi Z, Chapnick DA, Liu X. Dynamics of TGF-β/
Smad signaling. FEBS Lett 2012; 586:1921-8; 
PMID:22710166; http://dx.doi.org/10.1016/j.
febslet.2012.03.063
47. Inman GJ, Nicolás FJ, Hill CS. Nucleocytoplasmic 
shuttling of Smads 2, 3, and 4 permits sensing of 
TGF-beta receptor activity. Mol Cell 2002; 10:283-
94; PMID:12191474; http://dx.doi.org/10.1016/
S1097-2765(02)00585-3
48. Saritas-Yildirim B, Silva EM. The role of targeted 
protein degradation in early neural development. 
Genesis 2014; 52:287-99; PMID:24623518; http://
dx.doi.org/10.1002/dvg.22771
49. Míguez DG. Network nonlinearities in drug 
treatment. Interdiscip Sci 2013; 5:85-94; 
PMID:23740389; http://dx.doi.org/10.1007/
s12539-013-0165-x
50. Levy L, Howell M, Das D, Harkin S, Episkopou 
V, Hill CS. Arkadia activates Smad3/Smad4-
dependent transcription by triggering signal-induced 
SnoN degradation. Mol Cell Biol 2007; 27:6068-
83; PMID:17591695; http://dx.doi.org/10.1128/
MCB.00664-07
51. Oltvai ZN, Barabási AL. Systems biology. Life’s 
complexity pyramid. Science 2002; 298:763-
4; PMID:12399572; http://dx.doi.org/10.1126/
science.1078563
52. Kicheva A, Cohen M, Briscoe J. Developmental 
pattern formation: insights from physics and biology. 
Science 2012; 338:210-2; PMID:23066071; http://
dx.doi.org/10.1126/science.1225182
53. Formosa-Jordan P, Ibañes M, Ares S, Frade JM. 
Regulation of neuronal differentiation at the 
neurogenic wavefront. Development 2012; 139:2321-
9; PMID:22669822; http://dx.doi.org/10.1242/
dev.076406
54. Kaern M, Míguez DG, Muñuzuri AP, Menzinger M. 
Control of chemical pattern formation by a clock-
and-wavefront type mechanism. Biophys Chem 
2004; 110:231-8; PMID:15228959; http://dx.doi.
org/10.1016/j.bpc.2004.02.006
55. Economou AD, Ohazama A, Porntaveetus T, 
Sharpe PT, Kondo S, Basson MA, Gritli-Linde A, 
Cobourne MT, Green JB. Periodic stripe formation 
by a Turing mechanism operating at growth zones 
in the mammalian palate. Nat Genet 2012; 44:348-
51; PMID:22344222; http://dx.doi.org/10.1038/
ng.1090
56. Sheth R, Marcon L, Bastida MF, Junco M, Quintana 
L, Dahn R, Kmita M, Sharpe J, Ros MA. Hox 
genes regulate digit patterning by controlling the 
wavelength of a Turing-type mechanism. Science 
2012; 338:1476-80; PMID:23239739; http://dx.doi.
org/10.1126/science.1226804
57. Míguez DG, Muñuzuri AP. On the orientation 
of stripes in fish skin patterning. Biophys Chem 
2006; 124:161-7; PMID:16844282; http://dx.doi.
org/10.1016/j.bpc.2006.06.014
58. Míguez DG. The role of asymmetric binding in 
ligand-receptor systems with 1:2 interaction ratio. 
Biophys Chem 2010; 148:74-81; PMID:20332059; 
http://dx.doi.org/10.1016/j.bpc.2010.02.012
59. Doldán-Martelli V, Guantes R, Míguez DG. A 
mathematical model for the rational design of 
chimeric ligands in selective drug therapies. CPT 
Pharmacometrics Syst Pharmacol 2013; 2:e26; 
PMID:23887616; http://dx.doi.org/10.1038/
psp.2013.2
60. Ruiz-Herrero T, Estrada J, Guantes R, Miguez DG. 
A tunable coarse-grained model for ligand-receptor 
interaction. PLoS Comput Biol 2013; 9:e1003274; 
PMID:24244115; http://dx.doi.org/10.1371/journal.
pcbi.1003274
